 - Female patients must be surgically sterile, postmenopausal minimum 1 year without menses and verified by follicular-stimulating hormone FSH levels, or agree to use contraception from the time of signing the informed consent form through 16 weeks following the last injection of study medication. Male patients must also agree to use birth control for either themselves or their partner, as appropriate, from the time of signing the informed consent form through 16 weeks following the last injection of study medication. 